Citation Impact
Citing Papers
Approximate Bayesian Inference for Latent Gaussian models by using Integrated Nested Laplace Approximations
2009 Standout
Geography and macroeconomics: New data and new findings
2006 StandoutNobel
Glomerular Function Time Trends in Long-Term Survivors of Childhood Cancer: A Longitudinal Study
2013
Serum trace elements and Cu/Zn ratio in breast cancer patients
1991
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
2004
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
Unilocular Retroperitoneal Cyst of Mesothelial Origin Presenting as a Renal Mass
2000 StandoutNobel
Determination of sets of solute descriptors from chromatographic measurements
2004 Standout
The EKZ/AMC childhood cancer survivor cohort: methodology, clinical characteristics, and data availability
2013
Management of cancer pain
1999 Standout
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
Interactive spatial data analysis in medical geography
1996
Breast cancer incidence and its possible spatial association with pesticide application in two counties of England
2004
Heavy metal contamination of soil and vegetables in suburban areas of Varanasi, India
2006 Standout
Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer
2007
Cancer Metastasis: Building a Framework
2006 Standout
Risk areas and neighborhood-level risk factors for Shigella dysenteriae 1 and Shigella flexneri
2007
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Soils: their implications to human health
2002 Standout
Educational Attainment Among Adult Survivors of Childhood Cancer in Great Britain: A Population-Based Cohort Study
2010
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Benign Cystic Mesothelioma of the Peritoneum
1988
The Use of Computed Tomography in Pediatrics and the Associated Radiation Exposure and Estimated Cancer Risk
2013 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group
2012
Assessing risk of heavy metals from consuming food grown on sewage irrigated soils and food chain transfer
2007 Standout
LATE EFFECTS OF TREATMENT FOR WILMS TUMOR
2009
Neuroblastoma
2007 Standout
Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians
2013 Standout
Pulmonary function impairment measured by pulmonary function tests in long-term survivors of childhood cancer
2011
Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform
2005
Radiation Dose Associated With Common Computed Tomography Examinations and the Associated Lifetime Attributable Risk of Cancer
2009 Standout
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
2005
Children’s exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations
2008
Health risk from heavy metals via consumption of food crops in the vicinity of Dabaoshan mine, South China
2008 Standout
SoilGrids1km — Global Soil Information Based on Automated Mapping
2014 Standout
Uncovering healthcare practitioners’ information processing using the think-aloud method: From paper-based guideline to clinical decision support system
2015
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
2003
Renal Cell Carcinoma in Children: The Detroit Experience
1996
Medical or health geography? Populations, peoples and places
1998
Molten organic salt phase for gas-liquid chromatography
1982
LATE EFFECTS OF TREATMENT FOR WILMS TUMOR
2009
Spatial Data Analysis
2003
Determination of BHT, Irganox 1076, and Irganox 1010 antioxidant additives in polyethylene by high performance liquid chromatography
1980
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Model-Based Geostatistics
1998 Standout
Influence of concurrent retention mechanisms on the determination of stationary phase selectivity in gas chromatography
1987
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators
1995 Standout
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Water Microbiology. Bacterial Pathogens and Water
2010 Standout
Combining Incompatible Spatial Data
2002
From medical to health geography: novelty, place and theory after a decade of change
2002 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Protic Ionic Liquids: Properties and Applications
2007 Standout
Electrospray interface for liquid chromatographs and mass spectrometers
1985 StandoutNobel
Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
2003
The Impact of Serious Illness on Patients' Families
1994
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Multivariable geostatistics in S: the gstat package
2004 Standout
Environmental influences in cancer aetiology
2005
Soil and human health: a review
1997
Favorable Prognosis for Patients 12 to 18 Months of Age With Stage 4 Nonamplified MYCN Neuroblastoma: A Children's Cancer Group Study
2005
Suffering in the Advanced Cancer Patient: A Definition and Taxonomy
1994
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
2005
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Aggregation of space-time processes
2003 StandoutNobel
GeoDa: An Introduction to Spatial Data Analysis
2005 Standout
An Explicit Link between Gaussian Fields and Gaussian Markov Random Fields: The Stochastic Partial Differential Equation Approach
2011 Standout
Novel triangle scheme for classification of gas chromatographic phases based on solvatochromic linear solvation energy relationships
1992
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of J R Mann being referenced
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
2001
Thirty‐year population‐based review of childhood renal tumours with an assessment of prognostic features including tumour DNA characteristics
1993
‘Clustering’—Real or Apparent?: Probability Maps of Childhood Cancer in the West Midlands Health Authority Region
1990
The United Kingdom children's cancer study group—the first 20 years of growth and development
1997
Caring for survivors of childhood cancers: The size of the problem
2006
Malignant peritoneal mesothelioma in childhood.
1988
Financial burden of childhood cancer.
1982
Selection of Preferred Liquid Phases
1973
Kriging the Local Risk of a Rare Disease from a Register of Diagnoses
1994
A geostatistical approach to the analysis of pattern in rare disease
1992
ULTRASOUND EXAMINATIONS IN PREGNANCY AND CHILDHOOD CANCER
1984
Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy
1985